期刊文献+

西洛酰胺对IL-1β诱导损伤的离体胰岛细胞的防护作用及其机制 被引量:2

Protective effect of phosphodiesterase inhibitor on interleukin-1β induced destruction of isolated rat pancreatic islet cells and its mechanism
下载PDF
导出
摘要 目的探讨磷酸二酯酶(phosphodiesterase,PDE)抑制剂对白细胞介素-1β(IL-1β)诱导损伤的离体雄性Wistar大鼠胰岛细胞的防护作用及其机制。方法采用离体培养的雄性Wistar大鼠胰岛细胞,分别检测IL-1β(30u/mL)及IL-1β与特异性Ⅲ型PDE抑制剂西洛酰胺(cilostamide,CIL)对胰岛细胞亚硝酸盐合成、胰岛素(Ins)分泌、环磷酸腺苷(cAMP)水平及细胞活性(MTT)的影响。结果以IL-1β诱导,离体雄性Wistar大鼠胰岛细胞亚硝酸盐合成显著增加,cAMP水平、Ins分泌及MTT值显著降低(P<0.001),而CIL能阻断这些作用(P<0.01),且具有显著剂量依赖性(r2=0.44,P<0.01)。结论CIL能够保护IL-1β诱导的离体鼠胰岛细胞损伤。 [Objective] To observe the protective effect of phosphodiesterase (PDE) inhibitor on interlenkin-1β(IL-1β) induced destruction of isolated rat pancreatic islet cells and its mechanism. [Methods] Isolated pancreatic islet cells from Wistar rats were cultured in vitro. Nitrite production, cAMP levels, insulin secreation and cell activity (MTT assay) in rat pancreatic islet cells incubated with IL-1β (30 U/mL), the specific PDE Ⅲ inhibitor cilostamide( CIL) singly and in combination, were measured. [Results] IL-1βinduced significant increase in nitrite production, decreased cAMP levels, insulin secreation and MTT assay (P <0.001), which were blocked by CIL (P <0.01), and the inhibition of NO production gradually enhanced by the increase of the concentration of CIL. Linear regression and t-test indicate CIL suppresses NO production in a dose-dependent manner (r2=0.44, P <0.01). [Conclusion] The results suggest that CIL can protect IL-1β-induced damage to islets .
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第11期1641-1643,1646,共4页 China Journal of Modern Medicine
基金 辽宁省社会发展基金(98225004)
关键词 一氧化氮 白细胞介素-1Β 特异性Ⅲ型PDE抑制剂 nitric oxide interleukin-1β the specific PDE Ⅲ inhibitor
  • 相关文献

参考文献9

  • 1MANDRUP-POULSEN T. Apoptotic signal transduction pathways in diabetes [J]. Biochem pharmacol, 2003, 66 (8): 1433-1440.
  • 2ZUMSTEG U, FREDERIC S, HOLLANDER GA. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β-cell damage [J]. Diabetes, 2000, 49: 39-47.
  • 3DAVID M. ESSAYAN, MD ROCKVILLE, MD. Cyclic nucleotide phosphodiesterases [J]. J Allergy Clin Immunol, 2001, 108:671-677.
  • 4JEONY IK, OH SH, CHUNG JH, et al. The stimulatory effect of IL-1 beta on the insulin secretion of rat pancreatic islet is notrelated with iNOS pathway[J]. Exp Mol Med, 2002, 34(1): 12-17.
  • 5EIZIRIK DL, FLODSTROMM M, KARISEN AE, et al. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells [J]. Diabetologia, 1996, 39:875-890.
  • 6ANTHONY J, WEINHAUS, NICHOLAS V, BHAGROO, T.CLARK BRELJI, et al. Role of cAMP in upregulation of insulin secretion during the adaptation of islets of langerhans to pregnancy [J]. Diabetes,1998, 47: 1426-1434.
  • 7BIELEKOVA B, LINCOLN A, MCFARLAND H et al. Therapeutic potential of phosphodiesterase-4 and-3 inhibitors in Th1-mediated autoimmune diseases[J]. J Immunol, 2000, 164:1117-1124.
  • 8LIJIN LIANG, EVETTE BESHAY, GERALD J. Prud'homme. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice[J]. Diabetes, 1998, 47: 570-575.
  • 9EVETTE BESHAY, FRANCE CROZE, GERALD J. Prud'homme.The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo[J]. Clinical Immunology, 2001, 98: 272-279.

同被引文献30

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部